Dr. Gail Lynn Wright, MD

Dr. Wright practices at HCA Florida Trinity Hospital in Trinity, Florida, part of HCA Healthcare.

Dr. Wright's NPI, 1669432290, was assigned on March 27, 2006. Dr. Wright graduated from University of North Carolina School of Medicine in 1983. Dr. Wright holds Florida license ME71516.

Dr. Wright's primary practice is HCA Florida Trinity Hospital, at 9330 Sr 54, Trinity, FL 34655 in Pasco County. The practice phone is (727) 834-4900.

Dr. Wright's primary practice is HCA Florida Trinity Hospital in Trinity, Florida, part of HCA Healthcare. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Wright to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wright practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Wright's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Wright is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Wright's licenses on file in 6 states: Florida, Georgia, South Carolina, North Carolina, Virginia and Maryland.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Wright treats.

CMS data shows 41,842 Medicare services from Dr. Wright across 35 procedure codes in 2024, for 637 Medicare patients. Medicare paid $786,294 for them.

CMS counts 637 Medicare patients who saw Dr. Wright in 2024. The largest group is 75 to 84, with 273 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wright's median patient age at 67, with 79% women.

In 2024, Dr. Wright wrote 1,046 Medicare Part D claims for 250 patients. 82% of them were for generic drugs. CMS names the drug for 766 of them, across 26 drugs with 11 or more claims each, at $1,626,499 in total drug cost. In 2023, CMS named 768 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Wright for performance year 2024, reported as part of a group. Dr. Wright accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Wright, published from 2017 to 2021. 2018 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Receptor, ErbB-2. Dr. Wright has published most often in Breast Cancer Res Treat. Dr. Wright's most frequent co-authors are Lowell L. Hart, MD, John D. Hainsworth, MD and Joyce Ann O'Shaughnessy, MD.

Dmand AI links Dr. Wright to 22 clinical trials, 7 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Neoplasm Metastasis and Breast Diseases. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Wright that name 4 trials.

CMS Open Payments shows 1,346 general payments to Dr. Wright from 93 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Genentech, Inc. paid the most, $6,615. It also lists 8 research payments totaling $26,773 from 2016 to 2018, naming 4 clinical trials.

Dmand AI lists 1 award for Dr. Wright, most recently CMS Stage 1 EHR in 2014.

Dr. Wright graduated from University of North Carolina School of Medicine in 1983. Dr. Wright is a member of AACR, ACCP, ACP, ASCO and IASLC.

Dr. Wright is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.